File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

postgraduate thesis: A systematic review on the effectiveness of the first-line treatment of gastroesophageal reflux disease in H. pylori infected patients

TitleA systematic review on the effectiveness of the first-line treatment of gastroesophageal reflux disease in H. pylori infected patients
Authors
Chan, Rebeca.陳懿雯.
Issue Date2011
PublisherThe University of Hong Kong (Pokfulam, Hong Kong)
Citation
Chan, R. [陳懿雯]. (2011). A systematic review on the effectiveness of the first-line treatment of gastroesophageal reflux disease in H. pylori infected patients. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b4755989
AbstractHelicobacter pylori (H.pylori) had been confirmed by the World Health Organization (WHO) as Group 1 carcinogens, in which it has been identified to be related with the development of gastric carcinoma. Gastroesophageal reflux disease (GERD) is less commonly found in Asia, while the number of H.pylori infection is considerably to be higher than that of the Western population. The relationship between H.pylori and GERD still remains ambiguous nowadays. One of the contributing factors affecting the level of gastric secretion might be due to the genetic cause. The aim of this review is to assess whether the current first-line therapy on GERD would be effective or not in relieving the symptoms of the patients with H.pylori infection.
DegreeMaster of Public Health
SubjectGastrointestinal system - Diseases - Treatment - Evaluation.
Dept/ProgramCommunity Medicine
Persistent Identifierhttp://hdl.handle.net/10722/174426
HKU Library Item IDb4755989

 

DC FieldValueLanguage
dc.contributor.authorChan, Rebeca.-
dc.contributor.author陳懿雯.-
dc.date.issued2011-
dc.identifier.citationChan, R. [陳懿雯]. (2011). A systematic review on the effectiveness of the first-line treatment of gastroesophageal reflux disease in H. pylori infected patients. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b4755989-
dc.identifier.urihttp://hdl.handle.net/10722/174426-
dc.description.abstractHelicobacter pylori (H.pylori) had been confirmed by the World Health Organization (WHO) as Group 1 carcinogens, in which it has been identified to be related with the development of gastric carcinoma. Gastroesophageal reflux disease (GERD) is less commonly found in Asia, while the number of H.pylori infection is considerably to be higher than that of the Western population. The relationship between H.pylori and GERD still remains ambiguous nowadays. One of the contributing factors affecting the level of gastric secretion might be due to the genetic cause. The aim of this review is to assess whether the current first-line therapy on GERD would be effective or not in relieving the symptoms of the patients with H.pylori infection.-
dc.languageeng-
dc.publisherThe University of Hong Kong (Pokfulam, Hong Kong)-
dc.relation.ispartofHKU Theses Online (HKUTO)-
dc.rightsThe author retains all proprietary rights, (such as patent rights) and the right to use in future works.-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.source.urihttp://hub.hku.hk/bib/B47559895-
dc.subject.lcshGastrointestinal system - Diseases - Treatment - Evaluation.-
dc.titleA systematic review on the effectiveness of the first-line treatment of gastroesophageal reflux disease in H. pylori infected patients-
dc.typePG_Thesis-
dc.identifier.hkulb4755989-
dc.description.thesisnameMaster of Public Health-
dc.description.thesislevelMaster-
dc.description.thesisdisciplineCommunity Medicine-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.5353/th_b4755989-
dc.date.hkucongregation2012-
dc.identifier.mmsid991033215329703414-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats